SE437766B - Forfarande for framstellning av en blandning av en antiinflammatorisk steroid och ett som drivemne anvendbart fluorkolvete - Google Patents
Forfarande for framstellning av en blandning av en antiinflammatorisk steroid och ett som drivemne anvendbart fluorkolveteInfo
- Publication number
- SE437766B SE437766B SE8103143A SE8103143A SE437766B SE 437766 B SE437766 B SE 437766B SE 8103143 A SE8103143 A SE 8103143A SE 8103143 A SE8103143 A SE 8103143A SE 437766 B SE437766 B SE 437766B
- Authority
- SE
- Sweden
- Prior art keywords
- propellant
- steroid
- mixture
- process according
- suspended
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K3/00—Materials not provided for elsewhere
- C09K3/30—Materials not provided for elsewhere for aerosols
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dispersion Chemistry (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI801610A FI63672C (fi) | 1980-05-19 | 1980-05-19 | Foerfarande foer framstaellning av en blandning av beklometasondipropionat och triklorfluormetan eller diklordifluormetan |
Publications (2)
Publication Number | Publication Date |
---|---|
SE8103143L SE8103143L (sv) | 1981-11-20 |
SE437766B true SE437766B (sv) | 1985-03-18 |
Family
ID=8513487
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8103143A SE437766B (sv) | 1980-05-19 | 1981-05-19 | Forfarande for framstellning av en blandning av en antiinflammatorisk steroid och ett som drivemne anvendbart fluorkolvete |
Country Status (21)
Country | Link |
---|---|
US (1) | US4347236A (es) |
JP (1) | JPS5716820A (es) |
AT (1) | AT380791B (es) |
BE (1) | BE888822A (es) |
CA (1) | CA1162852A (es) |
CH (1) | CH647408A5 (es) |
CS (1) | CS221831B2 (es) |
DD (1) | DD158856A5 (es) |
DE (1) | DE3119745A1 (es) |
DK (1) | DK218481A (es) |
ES (1) | ES8203606A1 (es) |
FI (1) | FI63672C (es) |
FR (1) | FR2482457A1 (es) |
GB (1) | GB2076422B (es) |
HU (1) | HU188093B (es) |
NL (1) | NL8102457A (es) |
NO (1) | NO155429C (es) |
PL (1) | PL127872B1 (es) |
PT (1) | PT72989B (es) |
SE (1) | SE437766B (es) |
SU (1) | SU1184428A3 (es) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5653962A (en) * | 1991-12-12 | 1997-08-05 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicaments |
US5658549A (en) * | 1991-12-12 | 1997-08-19 | Glaxo Group Limited | Aerosol formulations containing propellant 134a and fluticasone propionate |
US5674471A (en) * | 1991-12-12 | 1997-10-07 | Glaxo Group Limited | Aerosol formulations containing P134a and salbutamol |
US5674472A (en) * | 1991-12-12 | 1997-10-07 | Glaxo Group Limited | Canisters containing aerosol formulations containing P134a and fluticasone propionate |
US5736124A (en) * | 1991-12-12 | 1998-04-07 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicament |
US5744123A (en) * | 1991-12-12 | 1998-04-28 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicaments |
US6200549B1 (en) | 1991-12-12 | 2001-03-13 | Glaxo Group Limited | Aerosol formulation containing P134a and particulate medicament |
US6333023B1 (en) | 1991-12-12 | 2001-12-25 | Glaxo Group Limited | Aerosol formulation containing particulate formoterol, propellant and polar cosolvent |
US6743413B1 (en) | 1991-12-18 | 2004-06-01 | 3M Company | Suspension aerosol formulations |
US7101534B1 (en) | 1991-12-18 | 2006-09-05 | 3M Innovative Properties Company | Suspension aerosol formulations |
US7994197B2 (en) | 2007-02-11 | 2011-08-09 | Map Pharmaceuticals, Inc. | Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile |
US8080236B2 (en) | 2002-04-17 | 2011-12-20 | Nektar Therapeutics Uk, Ltd | Particulate materials |
US9394314B2 (en) | 2012-12-21 | 2016-07-19 | Map Pharmaceuticals, Inc. | 8′-hydroxy-dihydroergotamine compounds and compositions |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR890000664B1 (ko) * | 1981-10-19 | 1989-03-22 | 바리 안소니 뉴우샘 | 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법 |
JP2573275B2 (ja) * | 1986-03-10 | 1997-01-22 | ブルグハルト,クルト | 薬学的製剤及びその製造法 |
JPH01156916A (ja) * | 1987-09-25 | 1989-06-20 | Ss Pharmaceut Co Ltd | 肝疾患治療剤 |
US7105152B1 (en) | 1991-12-18 | 2006-09-12 | 3M Innovative Properties Company | Suspension aerosol formulations |
GB9202519D0 (en) * | 1992-02-06 | 1992-03-25 | Glaxo Group Ltd | Medicaments |
US5376359A (en) * | 1992-07-07 | 1994-12-27 | Glaxo, Inc. | Method of stabilizing aerosol formulations |
MX9304585A (es) * | 1992-07-31 | 1994-03-31 | Glaxo Group Ltd | Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata. |
US7582284B2 (en) | 2002-04-17 | 2009-09-01 | Nektar Therapeutics | Particulate materials |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE629985A (es) * | 1962-11-29 | |||
GB1429184A (en) * | 1972-04-20 | 1976-03-24 | Allen & Hanburys Ltd | Physically anti-inflammatory steroids for use in aerosols |
JPS531814A (en) * | 1976-06-28 | 1978-01-10 | Toshiba Corp | Control unit of induction motor |
US4225597A (en) * | 1976-10-01 | 1980-09-30 | Schering Corporation | Beclomethasone dipropionate-hexane solvate and aerosols prepared therefrom |
IT1121513B (it) * | 1979-05-28 | 1986-04-02 | Chiesi Farma Spa | Processo per la conversione di umo steroide antiinfiammatorio in una forma suscettibile di essere somministarta come aerosol |
-
1980
- 1980-05-19 FI FI801610A patent/FI63672C/fi not_active IP Right Cessation
-
1981
- 1981-04-21 AT AT0179181A patent/AT380791B/de not_active IP Right Cessation
- 1981-04-24 GB GB8112683A patent/GB2076422B/en not_active Expired
- 1981-04-29 CA CA000376540A patent/CA1162852A/en not_active Expired
- 1981-05-06 PT PT72989A patent/PT72989B/pt unknown
- 1981-05-15 BE BE0/204802A patent/BE888822A/fr unknown
- 1981-05-15 FR FR8109719A patent/FR2482457A1/fr active Granted
- 1981-05-15 CH CH3165/81A patent/CH647408A5/de not_active IP Right Cessation
- 1981-05-18 HU HU811405A patent/HU188093B/hu unknown
- 1981-05-18 DE DE19813119745 patent/DE3119745A1/de not_active Withdrawn
- 1981-05-18 DK DK218481A patent/DK218481A/da not_active Application Discontinuation
- 1981-05-18 ES ES502286A patent/ES8203606A1/es not_active Expired
- 1981-05-18 SU SU813283353A patent/SU1184428A3/ru active
- 1981-05-18 DD DD81230036A patent/DD158856A5/de unknown
- 1981-05-18 PL PL1981231220A patent/PL127872B1/pl unknown
- 1981-05-18 CS CS813676A patent/CS221831B2/cs unknown
- 1981-05-18 NO NO811686A patent/NO155429C/no unknown
- 1981-05-19 NL NL8102457A patent/NL8102457A/nl not_active Application Discontinuation
- 1981-05-19 SE SE8103143A patent/SE437766B/sv not_active IP Right Cessation
- 1981-05-19 US US06/265,333 patent/US4347236A/en not_active Expired - Fee Related
- 1981-05-19 JP JP7433181A patent/JPS5716820A/ja active Pending
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6919069B2 (en) | 1991-12-12 | 2005-07-19 | Glaxo Group Limited | Aerosol formulation containing particulate formoterol, propellant and polar cosolvent |
US6333023B1 (en) | 1991-12-12 | 2001-12-25 | Glaxo Group Limited | Aerosol formulation containing particulate formoterol, propellant and polar cosolvent |
US5674471A (en) * | 1991-12-12 | 1997-10-07 | Glaxo Group Limited | Aerosol formulations containing P134a and salbutamol |
US5674472A (en) * | 1991-12-12 | 1997-10-07 | Glaxo Group Limited | Canisters containing aerosol formulations containing P134a and fluticasone propionate |
US5736124A (en) * | 1991-12-12 | 1998-04-07 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicament |
US5744123A (en) * | 1991-12-12 | 1998-04-28 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicaments |
US6200549B1 (en) | 1991-12-12 | 2001-03-13 | Glaxo Group Limited | Aerosol formulation containing P134a and particulate medicament |
US6238647B1 (en) | 1991-12-12 | 2001-05-29 | Glaxo Group Limited | Aerosol formulations containing salmeterol xinafoate, an anticholinergic agent and tetrafluoroethane |
US6251368B1 (en) | 1991-12-12 | 2001-06-26 | Glaxo Group Limited | Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant |
US6303103B1 (en) | 1991-12-12 | 2001-10-16 | Glaxo Group Limited | Aerosols containing salmeterol xinafoate and an anticholinergic medicament |
US6306369B1 (en) | 1991-12-12 | 2001-10-23 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicament |
US6893628B2 (en) | 1991-12-12 | 2005-05-17 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicament |
US5653962A (en) * | 1991-12-12 | 1997-08-05 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicaments |
US5658549A (en) * | 1991-12-12 | 1997-08-19 | Glaxo Group Limited | Aerosol formulations containing propellant 134a and fluticasone propionate |
US7498020B2 (en) | 1991-12-12 | 2009-03-03 | Glaxo Group Limited | Medicaments |
US7101534B1 (en) | 1991-12-18 | 2006-09-05 | 3M Innovative Properties Company | Suspension aerosol formulations |
US6743413B1 (en) | 1991-12-18 | 2004-06-01 | 3M Company | Suspension aerosol formulations |
US8080236B2 (en) | 2002-04-17 | 2011-12-20 | Nektar Therapeutics Uk, Ltd | Particulate materials |
US10251881B2 (en) | 2002-04-17 | 2019-04-09 | Nektar Therapeutics | Particulate materials |
US8828359B2 (en) | 2002-04-17 | 2014-09-09 | Nektar Therapeutics | Particulate materials |
US9616060B2 (en) | 2002-04-17 | 2017-04-11 | Nektar Therapeutics | Particulate materials |
US8470301B2 (en) | 2002-04-17 | 2013-06-25 | Nektar Therapeutics | Particulate materials |
US9833451B2 (en) | 2007-02-11 | 2017-12-05 | Map Pharmaceuticals, Inc. | Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile |
US8148377B2 (en) | 2007-02-11 | 2012-04-03 | Map Pharmaceuticals, Inc. | Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile |
US8119639B2 (en) | 2007-02-11 | 2012-02-21 | Map Pharmaceuticals, Inc. | Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile |
US10172853B2 (en) | 2007-02-11 | 2019-01-08 | Map Pharmaceuticals, Inc. | Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile |
US7994197B2 (en) | 2007-02-11 | 2011-08-09 | Map Pharmaceuticals, Inc. | Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile |
US9394314B2 (en) | 2012-12-21 | 2016-07-19 | Map Pharmaceuticals, Inc. | 8′-hydroxy-dihydroergotamine compounds and compositions |
Also Published As
Publication number | Publication date |
---|---|
GB2076422A (en) | 1981-12-02 |
US4347236A (en) | 1982-08-31 |
SU1184428A3 (ru) | 1985-10-07 |
NO811686L (no) | 1981-11-20 |
ES502286A0 (es) | 1982-04-01 |
FI63672B (fi) | 1983-04-29 |
ES8203606A1 (es) | 1982-04-01 |
DD158856A5 (de) | 1983-02-09 |
CS221831B2 (en) | 1983-04-29 |
NO155429B (no) | 1986-12-22 |
DE3119745A1 (de) | 1982-02-11 |
SE8103143L (sv) | 1981-11-20 |
CH647408A5 (de) | 1985-01-31 |
FR2482457A1 (fr) | 1981-11-20 |
PT72989A (en) | 1981-06-01 |
ATA179181A (de) | 1985-12-15 |
PL127872B1 (en) | 1983-12-31 |
HU188093B (en) | 1986-03-28 |
PL231220A1 (es) | 1982-01-18 |
CA1162852A (en) | 1984-02-28 |
FR2482457B1 (es) | 1985-01-04 |
AT380791B (de) | 1986-07-10 |
DK218481A (da) | 1981-11-20 |
JPS5716820A (en) | 1982-01-28 |
FI63672C (fi) | 1983-08-10 |
PT72989B (en) | 1983-07-06 |
FI801610A (fi) | 1981-11-20 |
NO155429C (no) | 1987-04-01 |
NL8102457A (nl) | 1981-12-16 |
GB2076422B (en) | 1983-12-14 |
BE888822A (fr) | 1981-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE437766B (sv) | Forfarande for framstellning av en blandning av en antiinflammatorisk steroid och ett som drivemne anvendbart fluorkolvete | |
AU587010B2 (en) | Physically modified beclomethasone dipropionate suitable for use in aerosols | |
US4188376A (en) | Stable liquid compositions containing salts of 1,2-benzisothiazolin-3-one | |
IL42038A (en) | Antiinflammatory steroids in the form of crystalline solvates and aerosol formulations containing them | |
JP5149199B2 (ja) | メソトリオンの結晶化方法 | |
JPH05208943A (ja) | N−(トランス−4−イソプロピルシクロヘキシルカルボニル)−d−フェニルアラニンの結晶及びその製造法 | |
US3157486A (en) | Pesticidal dispersion and method for preparing the same | |
CA1274503A (en) | Preparation and use of new solvates of beclomethasone 17,21-dipropionate | |
US3838194A (en) | Process for making hexagonal macrocrystals of aluminum hydride | |
CA1087958A (en) | Process for the preparation of concentrated suspensions | |
Head | Ice nucleation by some cyclic compounds | |
DE947159C (de) | Verfahren zur Herstellung von Sulfochloridgruppen tragenden Isocyanaten | |
BG97767A (bg) | Бензендиметанол,подходящ за микронизиране | |
NL8003049A (nl) | Werkwijze voor het omzetten van een ontsteking werend steroide in een voor toediening met aerosol geschikte vorm. | |
US20160271145A1 (en) | Method for enlarging the particle size of crystalline microparticles of active substance | |
CN108586281B (zh) | 一种氯化三甲基胺乙酰肼的制备方法 | |
FI67299B (fi) | Foerfarande foer framstaellning av ett alkansolvat av beklometasondipropionat | |
US3539632A (en) | Diethylmethyl(2-phenylallyl) ammonium iodide | |
US2357830A (en) | Manufacture of explosives | |
JPH03178990A (ja) | クロロフルオロカーボンを基剤とした微細結晶計量エアゾールでの使用に適する特別の結晶性向を示すジプロピオン酸ベクロメタゾンの製造方法 | |
US20080096970A1 (en) | Stable Nateglinide Form B Compositions | |
JPH08113547A (ja) | 大粒子径2,2−ビス(3,5−ジブロモ−4−ジブロモプロポキシフェニル)プロパン及びその製造方法 | |
JPS62168539A (ja) | カプセルの製法 | |
JPS6127366B2 (es) | ||
Thomson | 93. Solvent effect in dielectric polarisation. Part III. The behaviour of ethyl alcohol in certain ethers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 8103143-7 Effective date: 19900518 Format of ref document f/p: F |